Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.335
+0.055 (4.30%)
Jun 29, 2026, 1:59 PM EDT - Market open
Lineage Cell Therapeutics Employees
As of December 31, 2025, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees did not change compared to the previous year.
Employees
77
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$191,935
Profits / Employee
-$833,844
Market Cap
332.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Abeona Therapeutics | 226 |
| Verastem | 102 |
| Neumora Therapeutics | 92 |
| Immuneering | 55 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
| Opus Genetics | 28 |
LCTX News
- 6 weeks ago - Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c) - TheFly
- 6 weeks ago - Lineage Cell Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Lineage Cell Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Lineage Cell Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - Lineage Cell Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 - Business Wire
- 2 months ago - Lineage Cell announces 36-month results from Phase 1/2a study of RG6501 - TheFly